Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-53,000
Closed -$5.21M 549
2025
Q2
$5.21M Buy
53,000
+21,000
+66% +$1.99M 0.2% 76
2025
Q1
$2.96M Buy
+32,000
New +$2.95M 0.07% 101
2024
Q4
Sell
-50,999
Closed -$4.92M 186
2024
Q3
$4.92M Buy
+50,999
New +$4.98M 0.18% 107

Other funds holding AMED

MUFG Securities EMEA's AMED Position: Q3 2025 in Review

MUFG Securities EMEA sold out of Amedisys (AMED) in Q3 2025, closing a stake of 53,000 shares — an estimated $5.21M sold.

MUFG Securities EMEA first reported a position in AMED in Q3 2024 and held it in 3 quarters. The position peaked at $5.21M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • MUFG Securities EMEA reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • MUFG Securities EMEA sold 53,000 Amedisys shares in Q3 2025, an estimated $5.21M.
  • MUFG Securities EMEA first reported a position in Amedisys in Q3 2024 and held it in 3 quarters.
  • MUFG Securities EMEA's Amedisys position peaked at $5.21M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on MUFG Securities EMEA's 13F filing for Q3 2025, filed 14 Nov 2025.